Skip to main content
SpringerLink
Log in

Efficacy of low glycemic index treatment in epileptic patients: a systematic review

  • Review
  • Published:
Acta Neurologica Belgica Aims and scope Submit manuscript

Abstract

Low glycemic index treatment (LGIT) is one of the new kinds of ketogenic diet (KD), designed to simplify the implementation of the KD. To date, several studies have attempted to determine the efficacy of LGIT in patients with epilepsy; however, their results are debatable. This study aims to retrieve all the LGIT studies to shed light on LGIT efficacy in epileptic patients. Electronic literature databases including MEDLINE/PubMed, Web of Science, Scopus, EMBASE were searched in July 2017. Interventional or observational studies exploring the efficacy of LGIT were included in the study. The National Heart, Lung, and Blood Institute quality assessment tool was used for the quality assessment of included studies. Two hundred and eighteen records were retrieved through a literature search. Following the screening process, eight studies were included. According to the ratings of the quality assessment tool, four studies were classified as good and four were categorized as fair. The result of the current study reveals that LGIT has a beneficial effect in patients with intractable epilepsy. However, more high-quality studies are required to determine the efficacy of LGIT in patients with intractable epilepsy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Kossoff EH, Zupec-Kania BA, Amark PE, Ballaban-Gil KR, Christina Bergqvist AG, Blackford R, Buchhalter JR, Caraballo RH, Helen Cross J, Dahlin MG, Donner EJ, Klepper J, Jehle RS, Kim HD, Christiana Liu YM, Nation J, Nordli DR Jr, Pfeifer HH, Rho JM, Stafstrom CE, Thiele EA, Turner Z, Wirrell EC, Wheless JW, Veggiotti P, Vining EP (2009) Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study Group. Epilepsia 50:304–317

    Article  PubMed  Google Scholar 

  2. Pasca L, De Giorgis V, Macasaet JA, Trentani C, Tagliabue A, Veggiotti P (2016) The changing face of dietary therapy for epilepsy. Eur J Pediatr 175:1267–1276

    Article  PubMed  CAS  Google Scholar 

  3. Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, Moshe SL, Perucca E, Wiebe S, French J (2010) Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 51:1069–1077

    Article  PubMed  CAS  Google Scholar 

  4. Laxer KD, Trinka E, Hirsch LJ, Cendes F, Langfitt J, Delanty N, Resnick T, Benbadis SR (2014) The consequences of refractory epilepsy and its treatment. Epilepsy Behav 37:59–70

    Article  PubMed  Google Scholar 

  5. Lopez Gonzalez FJ, Rodriguez Osorio X, Gil-Nagel Rein A, Carreno Martinez M, Serratosa Fernandez J, Villanueva Haba V, Donaire Pedraza AJ, Mercade Cerda JM (2015) Drug-resistant epilepsy: definition and treatment alternatives. Neurologia 30:439–446

    Article  PubMed  CAS  Google Scholar 

  6. Karimzadeh P, Sedighi M, Beheshti M, Azargashb E, Ghofrani M, Abdollahe-Gorgi F (2014) Low glycemic index treatment in pediatric refractory epilepsy: the first middle east report. Seizure 23:570–572

    Article  PubMed  Google Scholar 

  7. Kwan P, Schachter SC, Brodie MJ (2011) Drug-resistant epilepsy. N Engl J Med 365:919–926

    Article  PubMed  CAS  Google Scholar 

  8. Parakh M, Katewa V (2014) Non-pharmacologic management of epilepsy. Indian J Pediatr 81:1073–1080

    Article  PubMed  Google Scholar 

  9. Wilder R (1921) The effects of ketonemia on the course of epilepsy. In: Mayo Clin Proc, pp 307–308

  10. Winesett SP, Bessone SK, Kossoff EH (2015) The ketogenic diet in pharmacoresistant childhood epilepsy. Expert Rev Neurother 15:621–628

    Article  PubMed  CAS  Google Scholar 

  11. Rezaei S, Abdurahman AA, Saghazadeh A, Badv RS, Mahmoudi M (2017) Short-term and long-term efficacy of classical ketogenic diet and modified Atkins diet in children and adolescents with epilepsy: a systematic review and meta-analysis. Nutr Neurosci. https://doi.org/10.1080/1028415X.2017.1387721

    Article  PubMed  Google Scholar 

  12. Zamani GR, Mohammadi M, Ashrafi MR, Karimi P, Mahmoudi M, Badv RS, Tavassoli AR, Azizi Malamiri R (2016) The effects of classic ketogenic diet on serum lipid profile in children with refractory seizures. Acta Neurol Belg 116:529–534

    Article  PubMed  Google Scholar 

  13. Neal EG, Chaffe H, Schwartz RH, Lawson MS, Edwards N, Fitzsimmons G, Whitney A, Cross JH (2009) A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy. Epilepsia 50:1109–1117

    Article  PubMed  Google Scholar 

  14. Kim JA, Yoon JR, Lee EJ, Lee JS, Kim JT, Kim HD, Kang HC (2016) Efficacy of the classic ketogenic and the modified Atkins diets in refractory childhood epilepsy. Epilepsia 57:51–58

    Article  PubMed  Google Scholar 

  15. Hallbook T, Sjolander A, Amark P, Miranda M, Bjurulf B, Dahlin M (2015) Effectiveness of the ketogenic diet used to treat resistant childhood epilepsy in Scandinavia. Eur J Paediatr Neurol 19:29–36

    Article  PubMed  Google Scholar 

  16. Satte A, Kossoff EH, Belghiti M, Zerhouni A, Ouhabi H, Guerinech H, Mounach J (2017) Why should modified Atkins diet be encouraged for treating epilepsy in emerging countries? Afr Health Sci 17:556–558

    Article  PubMed  PubMed Central  Google Scholar 

  17. Kossoff EH, Al-Macki N, Cervenka MC, Kim HD, Liao J, Megaw K, Nathan JK, Raimann X, Rivera R, Wiemer-Kruel A, Williams E, Zupec-Kania BA (2015) What are the minimum requirements for ketogenic diet services in resource-limited regions? Recommendations from the International League Against Epilepsy Task Force for Dietary Therapy. Epilepsia 56:1337–1342

    Article  PubMed  Google Scholar 

  18. Kessler SK, Neal EG, Camfield CS, Kossoff EH (2011) Dietary therapies for epilepsy: future research. Epilepsy Behav 22:17–22

    Article  PubMed  PubMed Central  Google Scholar 

  19. Cervenka MC, Kossoff EH (2013) Dietary treatment of intractable epilepsy. Continuum (Minneap Minn) 19:756–766

    Google Scholar 

  20. Pfeifer HH, Thiele EA (2005) Low-glycemic-index treatment: a liberalized ketogenic diet for treatment of intractable epilepsy. Neurology 65:1810–1812

    Article  PubMed  CAS  Google Scholar 

  21. Miranda MJ, Turner Z, Magrath G (2012) Alternative diets to the classical ketogenic diet—can we be more liberal? Epilepsy Res 100:278–285

    Article  PubMed  Google Scholar 

  22. Pfeifer HH, Lyczkowski DA, Thiele EA (2008) Low glycemic index treatment: implementation and new insights into efficacy. Epilepsia 49:42–45

    Article  PubMed  Google Scholar 

  23. Kossoff EH, Wang HS (2013) Dietary therapies for epilepsy. Biomed J 36:2–8

    Article  PubMed  Google Scholar 

  24. Coppola G, D’Aniello A, Messana T, Di Pasquale F, della Corte R, Pascotto A, Verrotti A (2011) Low glycemic index diet in children and young adults with refractory epilepsy: first Italian experience. Seizure 20:526–528

    Article  PubMed  Google Scholar 

  25. Kim SH, Kang HC, Lee EJ, Lee JS, Kim HD (2017) Low glycemic index treatment in patients with drug-resistant epilepsy. Brain Dev 39:687–692. https://doi.org/10.1016/j.braindev.2017.03.027

    Article  PubMed  Google Scholar 

  26. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097

    Article  PubMed  PubMed Central  Google Scholar 

  27. Health, N.I.o (2014) National Heart Lung, and Blood Institute. Quality assessment tool for observational cohort and cross-sectional studies

  28. Thibert RL, Pfeifer HH, Larson AM, Raby AR, Reynolds AA, Morgan AK, Thiele EA (2012) Low glycemic index treatment for seizures in Angelman syndrome. Epilepsia 53:1498–1502

    Article  PubMed  CAS  Google Scholar 

  29. Grocott OR, Herrington KS, Pfeifer HH, Thiele EA, Thibert RL (2017) Low glycemic index treatment for seizure control in Angelman syndrome: a case series from the Center for Dietary Therapy of Epilepsy at the Massachusetts General Hospital. Epilepsy Behav 68:45–50

    Article  PubMed  Google Scholar 

  30. Larson AM, Pfeifer HH, Thiele EA (2012) Low glycemic index treatment for epilepsy in tuberous sclerosis complex. Epilepsy Res 99:180–182

    Article  PubMed  Google Scholar 

  31. Muzykewicz DA, Lyczkowski DA, Memon N, Conant KD, Pfeifer HH, Thiele EA (2009) Efficacy, safety, and tolerability of the low glycemic index treatment in pediatric epilepsy. Epilepsia 50:1118–1126

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This research has been supported by Tehran University of Medical Sciences (Grant no: 96-03-61-35984).

Funding

None.

Author information

Authors and Affiliations

  1. Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, 14155-6447, Iran

    Shahabeddin Rezaei, Mona Kavoosi & Maryam Mahmoudi

  2. Students’ Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran

    Shahabeddin Rezaei & Sara Harsini

  3. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran

    Sara Harsini

  4. Department of Paediatric Neurology, Paediatrics Centre of Excellence, Children’s Medical Centre, Tehran University of Medical Sciences, Tehran, Iran

    Reza Shervin Badv

  5. Pediatric Gastroenterology and Hepatology Research Center, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran

    Maryam Mahmoudi

  6. Dietitians and Nutrition Experts Team (DiNET), Universal Scientific Education and Research Network (USERN), Tehran, Iran

    Maryam Mahmoudi

Authors
  1. Shahabeddin Rezaei
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sara Harsini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mona Kavoosi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Reza Shervin Badv
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Maryam Mahmoudi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maryam Mahmoudi.

Ethics declarations

Conflict of interest

The authors declare no conflicts of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

For this type of study, formal consent form is not required.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rezaei, S., Harsini, S., Kavoosi, M. et al. Efficacy of low glycemic index treatment in epileptic patients: a systematic review. Acta Neurol Belg 118, 339–349 (2018). https://doi.org/10.1007/s13760-018-0881-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13760-018-0881-4

Keywords

Search

Navigation